nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—hematologic cancer—muscle cancer	0.594	1	CtDrD
Vorinostat—NR0B1—Vincristine—muscle cancer	0.239	1	CbGbCtD
Vorinostat—HDAC1—manus—muscle cancer	0.00437	0.0879	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Etoposide—muscle cancer	0.00227	0.0702	CcSEcCtD
Vorinostat—HDAC8—renal system—muscle cancer	0.00163	0.0328	CbGeAlD
Vorinostat—HDAC3—embryo—muscle cancer	0.0016	0.0321	CbGeAlD
Vorinostat—HDAC1—embryo—muscle cancer	0.00146	0.0294	CbGeAlD
Vorinostat—HDAC11—renal system—muscle cancer	0.00142	0.0286	CbGeAlD
Vorinostat—NCOR1—renal system—muscle cancer	0.00138	0.0277	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Methotrexate—muscle cancer	0.00136	0.042	CcSEcCtD
Vorinostat—Ureteric obstruction—Methotrexate—muscle cancer	0.00136	0.042	CcSEcCtD
Vorinostat—HDAC2—Teniposide—Etoposide—muscle cancer	0.00132	1	CbGdCrCtD
Vorinostat—HDAC8—tendon—muscle cancer	0.00127	0.0256	CbGeAlD
Vorinostat—HDAC4—tendon—muscle cancer	0.00124	0.0249	CbGeAlD
Vorinostat—HDAC8—bone marrow—muscle cancer	0.00123	0.0248	CbGeAlD
Vorinostat—HDAC6—head—muscle cancer	0.00123	0.0247	CbGeAlD
Vorinostat—HDAC4—bone marrow—muscle cancer	0.0012	0.0241	CbGeAlD
Vorinostat—HDAC6—testis—muscle cancer	0.00119	0.0239	CbGeAlD
Vorinostat—HDAC8—vagina—muscle cancer	0.00118	0.0237	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Doxorubicin—muscle cancer	0.00118	0.0364	CcSEcCtD
Vorinostat—Ureteric obstruction—Doxorubicin—muscle cancer	0.00118	0.0364	CcSEcCtD
Vorinostat—HDAC1—smooth muscle tissue—muscle cancer	0.00115	0.0231	CbGeAlD
Vorinostat—HDAC1—renal system—muscle cancer	0.00111	0.0223	CbGeAlD
Vorinostat—Myelosuppression—Dactinomycin—muscle cancer	0.0011	0.0339	CcSEcCtD
Vorinostat—HDAC3—cardiac atrium—muscle cancer	0.00108	0.0218	CbGeAlD
Vorinostat—HDAC4—head—muscle cancer	0.00106	0.0213	CbGeAlD
Vorinostat—HDAC8—testis—muscle cancer	0.00105	0.0212	CbGeAlD
Vorinostat—NCOR1—bone marrow—muscle cancer	0.00104	0.021	CbGeAlD
Vorinostat—HDAC11—vagina—muscle cancer	0.00103	0.0207	CbGeAlD
Vorinostat—HDAC4—testis—muscle cancer	0.00102	0.0206	CbGeAlD
Vorinostat—HDAC1—cardiac atrium—muscle cancer	0.000992	0.0199	CbGeAlD
Vorinostat—Myelosuppression—Vincristine—muscle cancer	0.000982	0.0303	CcSEcCtD
Vorinostat—HDAC11—head—muscle cancer	0.000951	0.0191	CbGeAlD
Vorinostat—HDAC3—tendon—muscle cancer	0.000944	0.019	CbGeAlD
Vorinostat—NCOR1—head—muscle cancer	0.000923	0.0186	CbGeAlD
Vorinostat—HDAC11—testis—muscle cancer	0.000919	0.0185	CbGeAlD
Vorinostat—HDAC3—bone marrow—muscle cancer	0.000914	0.0184	CbGeAlD
Vorinostat—NCOR1—testis—muscle cancer	0.000892	0.0179	CbGeAlD
Vorinostat—HDAC3—vagina—muscle cancer	0.000876	0.0176	CbGeAlD
Vorinostat—HDAC1—tendon—muscle cancer	0.000864	0.0174	CbGeAlD
Vorinostat—HDAC9—tendon—muscle cancer	0.00085	0.0171	CbGeAlD
Vorinostat—HDAC1—bone marrow—muscle cancer	0.000837	0.0168	CbGeAlD
Vorinostat—NR0B1—testis—muscle cancer	0.000837	0.0168	CbGeAlD
Vorinostat—HDAC9—bone marrow—muscle cancer	0.000824	0.0166	CbGeAlD
Vorinostat—HDAC3—head—muscle cancer	0.000809	0.0163	CbGeAlD
Vorinostat—HDAC1—vagina—muscle cancer	0.000802	0.0161	CbGeAlD
Vorinostat—Myelosuppression—Etoposide—muscle cancer	0.000795	0.0246	CcSEcCtD
Vorinostat—HDAC3—testis—muscle cancer	0.000781	0.0157	CbGeAlD
Vorinostat—HDAC1—head—muscle cancer	0.000741	0.0149	CbGeAlD
Vorinostat—HDAC2—embryo—muscle cancer	0.000736	0.0148	CbGeAlD
Vorinostat—HDAC9—head—muscle cancer	0.000729	0.0147	CbGeAlD
Vorinostat—HDAC1—testis—muscle cancer	0.000716	0.0144	CbGeAlD
Vorinostat—HDAC9—testis—muscle cancer	0.000704	0.0142	CbGeAlD
Vorinostat—Thromboembolism—Doxorubicin—muscle cancer	0.000608	0.0188	CcSEcCtD
Vorinostat—HDAC2—smooth muscle tissue—muscle cancer	0.000578	0.0116	CbGeAlD
Vorinostat—HDAC2—renal system—muscle cancer	0.000557	0.0112	CbGeAlD
Vorinostat—Sepsis—Dactinomycin—muscle cancer	0.000447	0.0138	CcSEcCtD
Vorinostat—HDAC2—tendon—muscle cancer	0.000435	0.00874	CbGeAlD
Vorinostat—HDAC2—bone marrow—muscle cancer	0.000421	0.00847	CbGeAlD
Vorinostat—Myelosuppression—Doxorubicin—muscle cancer	0.000413	0.0127	CcSEcCtD
Vorinostat—HDAC2—vagina—muscle cancer	0.000403	0.00811	CbGeAlD
Vorinostat—Embolism venous—Doxorubicin—muscle cancer	0.000383	0.0118	CcSEcCtD
Vorinostat—Lethargy—Dactinomycin—muscle cancer	0.000382	0.0118	CcSEcCtD
Vorinostat—HDAC2—head—muscle cancer	0.000373	0.00749	CbGeAlD
Vorinostat—Deep vein thrombosis—Methotrexate—muscle cancer	0.000367	0.0113	CcSEcCtD
Vorinostat—HDAC2—testis—muscle cancer	0.00036	0.00724	CbGeAlD
Vorinostat—Embolism—Methotrexate—muscle cancer	0.000348	0.0107	CcSEcCtD
Vorinostat—Sepsis—Etoposide—muscle cancer	0.000324	0.00999	CcSEcCtD
Vorinostat—Serum creatinine increased—Doxorubicin—muscle cancer	0.000315	0.00971	CcSEcCtD
Vorinostat—Dehydration—Vincristine—muscle cancer	0.000311	0.0096	CcSEcCtD
Vorinostat—Pancytopenia—Dactinomycin—muscle cancer	0.000307	0.00948	CcSEcCtD
Vorinostat—Neutropenia—Dactinomycin—muscle cancer	0.000302	0.00933	CcSEcCtD
Vorinostat—Embolism—Doxorubicin—muscle cancer	0.000301	0.0093	CcSEcCtD
Vorinostat—Abscess—Methotrexate—muscle cancer	0.000282	0.00872	CcSEcCtD
Vorinostat—Pancytopenia—Vincristine—muscle cancer	0.000274	0.00847	CcSEcCtD
Vorinostat—Neutropenia—Vincristine—muscle cancer	0.00027	0.00834	CcSEcCtD
Vorinostat—Weight decreased—Vincristine—muscle cancer	0.000261	0.00807	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—muscle cancer	0.000254	0.00785	CcSEcCtD
Vorinostat—Acute coronary syndrome—Vincristine—muscle cancer	0.000254	0.00784	CcSEcCtD
Vorinostat—Myocardial infarction—Vincristine—muscle cancer	0.000253	0.0078	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—muscle cancer	0.000251	0.00774	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—muscle cancer	0.000245	0.00755	CcSEcCtD
Vorinostat—Chills—Dactinomycin—muscle cancer	0.000232	0.00717	CcSEcCtD
Vorinostat—Alopecia—Dactinomycin—muscle cancer	0.000229	0.00706	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—muscle cancer	0.000227	0.00699	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—muscle cancer	0.000223	0.0069	CcSEcCtD
Vorinostat—Pancytopenia—Etoposide—muscle cancer	0.000222	0.00686	CcSEcCtD
Vorinostat—Neutropenia—Etoposide—muscle cancer	0.000219	0.00676	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—muscle cancer	0.000208	0.00643	CcSEcCtD
Vorinostat—Acute coronary syndrome—Etoposide—muscle cancer	0.000206	0.00635	CcSEcCtD
Vorinostat—Myocardial infarction—Etoposide—muscle cancer	0.000205	0.00631	CcSEcCtD
Vorinostat—Alopecia—Vincristine—muscle cancer	0.000204	0.00631	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—muscle cancer	0.000202	0.00623	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—muscle cancer	0.000194	0.00599	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—muscle cancer	0.000193	0.00597	CcSEcCtD
Vorinostat—Anaemia—Vincristine—muscle cancer	0.000186	0.00574	CcSEcCtD
Vorinostat—Infection—Dactinomycin—muscle cancer	0.000183	0.00564	CcSEcCtD
Vorinostat—Leukopenia—Vincristine—muscle cancer	0.00018	0.00556	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—muscle cancer	0.00018	0.00556	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—muscle cancer	0.000175	0.00541	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000172	0.00531	CcSEcCtD
Vorinostat—Chills—Etoposide—muscle cancer	0.000168	0.00519	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—muscle cancer	0.000168	0.00518	CcSEcCtD
Vorinostat—Alopecia—Etoposide—muscle cancer	0.000166	0.00511	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—muscle cancer	0.000166	0.00511	CcSEcCtD
Vorinostat—Infection—Vincristine—muscle cancer	0.000163	0.00504	CcSEcCtD
Vorinostat—Thrombocytopenia—Vincristine—muscle cancer	0.000161	0.00497	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—muscle cancer	0.00016	0.00493	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—muscle cancer	0.00016	0.00493	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—muscle cancer	0.000159	0.00489	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—muscle cancer	0.000157	0.00484	CcSEcCtD
Vorinostat—Anorexia—Vincristine—muscle cancer	0.000157	0.00483	CcSEcCtD
Vorinostat—Anaemia—Etoposide—muscle cancer	0.000151	0.00465	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000149	0.00459	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—muscle cancer	0.000146	0.00451	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—muscle cancer	0.000145	0.00449	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—muscle cancer	0.000143	0.00442	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—muscle cancer	0.000143	0.00442	CcSEcCtD
Vorinostat—Decreased appetite—Vincristine—muscle cancer	0.000143	0.00441	CcSEcCtD
Vorinostat—Cough—Etoposide—muscle cancer	0.000142	0.00439	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vincristine—muscle cancer	0.000142	0.00438	CcSEcCtD
Vorinostat—Fatigue—Vincristine—muscle cancer	0.000142	0.00437	CcSEcCtD
Vorinostat—Constipation—Vincristine—muscle cancer	0.00014	0.00434	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00014	0.00434	CcSEcCtD
Vorinostat—Chest pain—Etoposide—muscle cancer	0.000139	0.00429	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—muscle cancer	0.000133	0.00411	CcSEcCtD
Vorinostat—Infection—Etoposide—muscle cancer	0.000132	0.00408	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—muscle cancer	0.000132	0.00407	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—muscle cancer	0.000132	0.00406	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—KIDINS220—muscle cancer	0.000131	0.00157	CbGpPWpGaD
Vorinostat—Neutropenia—Methotrexate—muscle cancer	0.000131	0.00405	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—muscle cancer	0.000131	0.00403	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—muscle cancer	0.00013	0.00402	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00013	0.00402	CcSEcCtD
Vorinostat—Body temperature increased—Vincristine—muscle cancer	0.00013	0.00401	CcSEcCtD
Vorinostat—NCOR1—Developmental Biology—MED12—muscle cancer	0.000128	0.00154	CbGpPWpGaD
Vorinostat—Hypokalaemia—Doxorubicin—muscle cancer	0.000128	0.00395	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle, Mitotic—BUB1B—muscle cancer	0.000128	0.00153	CbGpPWpGaD
Vorinostat—Anorexia—Etoposide—muscle cancer	0.000127	0.00392	CcSEcCtD
Vorinostat—HDAC6—Signaling by NOTCH—TP53—muscle cancer	0.000126	0.00151	CbGpPWpGaD
Vorinostat—Diarrhoea—Dactinomycin—muscle cancer	0.000126	0.00388	CcSEcCtD
Vorinostat—HDAC1—Hemostasis—ANGPT2—muscle cancer	0.000126	0.00151	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CDKN2A—muscle cancer	0.000125	0.0015	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000124	0.00149	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MDM2—muscle cancer	0.000121	0.00146	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KIDINS220—muscle cancer	0.000121	0.00145	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—FOXO4—muscle cancer	0.00012	0.00144	CbGpPWpGaD
Vorinostat—HDAC4—Cell Cycle—TP53—muscle cancer	0.00012	0.00144	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—FOXO1—muscle cancer	0.000118	0.00142	CbGpPWpGaD
Vorinostat—Asthenia—Vincristine—muscle cancer	0.000118	0.00364	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—muscle cancer	0.000117	0.00361	CcSEcCtD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000117	0.0014	CbGpPWpGaD
Vorinostat—Decreased appetite—Etoposide—muscle cancer	0.000116	0.00357	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—muscle cancer	0.000115	0.00356	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—muscle cancer	0.000115	0.00355	CcSEcCtD
Vorinostat—Fatigue—Etoposide—muscle cancer	0.000115	0.00354	CcSEcCtD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000114	0.00137	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—BUB1B—muscle cancer	0.000114	0.00137	CbGpPWpGaD
Vorinostat—Constipation—Etoposide—muscle cancer	0.000114	0.00351	CcSEcCtD
Vorinostat—HDAC4—Signaling by NOTCH—TP53—muscle cancer	0.000114	0.00136	CbGpPWpGaD
Vorinostat—Neutropenia—Doxorubicin—muscle cancer	0.000114	0.0035	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—KIDINS220—muscle cancer	0.000113	0.00136	CbGpPWpGaD
Vorinostat—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000113	0.00348	CcSEcCtD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000113	0.00135	CbGpPWpGaD
Vorinostat—Diarrhoea—Vincristine—muscle cancer	0.000112	0.00347	CcSEcCtD
Vorinostat—HDAC6—Cellular responses to stress—CDKN2A—muscle cancer	0.000111	0.00134	CbGpPWpGaD
Vorinostat—HDAC1—Generic Transcription Pathway—MED12—muscle cancer	0.000111	0.00133	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—TP53—muscle cancer	0.000111	0.00133	CbGpPWpGaD
Vorinostat—Weight decreased—Doxorubicin—muscle cancer	0.00011	0.00339	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—muscle cancer	0.000109	0.00338	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—muscle cancer	0.000109	0.00337	CcSEcCtD
Vorinostat—Dizziness—Vincristine—muscle cancer	0.000109	0.00335	CcSEcCtD
Vorinostat—NCOR1—Signaling by ERBB4—MDM2—muscle cancer	0.000108	0.0013	CbGpPWpGaD
Vorinostat—HDAC6—Cellular responses to stress—MDM2—muscle cancer	0.000108	0.0013	CbGpPWpGaD
Vorinostat—Body temperature increased—Etoposide—muscle cancer	0.000105	0.00325	CcSEcCtD
Vorinostat—HDAC8—Signaling by NOTCH—TP53—muscle cancer	0.000105	0.00126	CbGpPWpGaD
Vorinostat—Vomiting—Vincristine—muscle cancer	0.000104	0.00322	CcSEcCtD
Vorinostat—Headache—Vincristine—muscle cancer	0.000103	0.00318	CcSEcCtD
Vorinostat—HDAC11—Disease—ENO2—muscle cancer	0.000103	0.00123	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KIDINS220—muscle cancer	0.000102	0.00122	CbGpPWpGaD
Vorinostat—Chills—Methotrexate—muscle cancer	0.000101	0.00311	CcSEcCtD
Vorinostat—HDAC1—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	0.0001	0.0012	CbGpPWpGaD
Vorinostat—Alopecia—Methotrexate—muscle cancer	9.92e-05	0.00306	CcSEcCtD
Vorinostat—HDAC9—Signaling by NOTCH—TP53—muscle cancer	9.82e-05	0.00118	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—FH—muscle cancer	9.81e-05	0.00118	CbGpPWpGaD
Vorinostat—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	9.8e-05	0.00118	CbGpPWpGaD
Vorinostat—Nausea—Vincristine—muscle cancer	9.76e-05	0.00301	CcSEcCtD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—VEGFA—muscle cancer	9.76e-05	0.00117	CbGpPWpGaD
Vorinostat—Oedema peripheral—Doxorubicin—muscle cancer	9.57e-05	0.00295	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—muscle cancer	9.57e-05	0.00295	CcSEcCtD
Vorinostat—Asthenia—Etoposide—muscle cancer	9.55e-05	0.00295	CcSEcCtD
Vorinostat—Pruritus—Etoposide—muscle cancer	9.42e-05	0.00291	CcSEcCtD
Vorinostat—NCOR1—Signaling Pathways—KIDINS220—muscle cancer	9.35e-05	0.00112	CbGpPWpGaD
Vorinostat—HDAC11—Disease—HMGA1—muscle cancer	9.33e-05	0.00112	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	9.32e-05	0.00112	CbGpPWpGaD
Vorinostat—HDAC3—Cell Cycle—TP53—muscle cancer	9.3e-05	0.00112	CbGpPWpGaD
Vorinostat—Diarrhoea—Etoposide—muscle cancer	9.11e-05	0.00281	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—muscle cancer	9.03e-05	0.00279	CcSEcCtD
Vorinostat—HDAC3—Signaling by NGF—KIT—muscle cancer	9.03e-05	0.00108	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—FH—muscle cancer	9.01e-05	0.00108	CbGpPWpGaD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	8.88e-05	0.00106	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	8.87e-05	0.00106	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—FOXO1—muscle cancer	8.87e-05	0.00106	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NOTCH—TP53—muscle cancer	8.82e-05	0.00106	CbGpPWpGaD
Vorinostat—Dizziness—Etoposide—muscle cancer	8.8e-05	0.00272	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—muscle cancer	8.74e-05	0.0027	CcSEcCtD
Vorinostat—Chills—Doxorubicin—muscle cancer	8.72e-05	0.00269	CcSEcCtD
Vorinostat—HDAC6—Disease—ENO2—muscle cancer	8.61e-05	0.00103	CbGpPWpGaD
Vorinostat—Alopecia—Doxorubicin—muscle cancer	8.59e-05	0.00265	CcSEcCtD
Vorinostat—Cough—Methotrexate—muscle cancer	8.52e-05	0.00263	CcSEcCtD
Vorinostat—Vomiting—Etoposide—muscle cancer	8.46e-05	0.00261	CcSEcCtD
Vorinostat—HDAC11—Disease—FOXO4—muscle cancer	8.37e-05	0.001	CbGpPWpGaD
Vorinostat—Headache—Etoposide—muscle cancer	8.34e-05	0.00257	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—muscle cancer	8.32e-05	0.00257	CcSEcCtD
Vorinostat—HDAC1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	8.3e-05	0.000995	CbGpPWpGaD
Vorinostat—Dysgeusia—Doxorubicin—muscle cancer	8.28e-05	0.00256	CcSEcCtD
Vorinostat—HDAC6—Cellular responses to stress—VEGFA—muscle cancer	8.21e-05	0.000984	CbGpPWpGaD
Vorinostat—Muscle spasms—Doxorubicin—muscle cancer	8.13e-05	0.00251	CcSEcCtD
Vorinostat—NCOR1—Signaling by NOTCH—TP53—muscle cancer	8.11e-05	0.000972	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—ANGPT2—muscle cancer	8.1e-05	0.000971	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—CDKN2A—muscle cancer	8.07e-05	0.000968	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—BUB1B—muscle cancer	8.03e-05	0.000963	CbGpPWpGaD
Vorinostat—Infection—Methotrexate—muscle cancer	7.92e-05	0.00244	CcSEcCtD
Vorinostat—HDAC1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	7.92e-05	0.000949	CbGpPWpGaD
Vorinostat—Nausea—Etoposide—muscle cancer	7.91e-05	0.00244	CcSEcCtD
Vorinostat—HDAC2—Cell Cycle—MDM2—muscle cancer	7.83e-05	0.000939	CbGpPWpGaD
Vorinostat—HDAC6—Disease—HMGA1—muscle cancer	7.82e-05	0.000938	CbGpPWpGaD
Vorinostat—Anaemia—Doxorubicin—muscle cancer	7.82e-05	0.00241	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—muscle cancer	7.81e-05	0.00241	CcSEcCtD
Vorinostat—HDAC4—Disease—ENO2—muscle cancer	7.78e-05	0.000933	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—FOXO4—muscle cancer	7.74e-05	0.000928	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MED12—muscle cancer	7.7e-05	0.000924	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—FOXO1—muscle cancer	7.65e-05	0.000917	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KIDINS220—muscle cancer	7.62e-05	0.000914	CbGpPWpGaD
Vorinostat—Anorexia—Methotrexate—muscle cancer	7.6e-05	0.00235	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—muscle cancer	7.58e-05	0.00234	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—muscle cancer	7.57e-05	0.00234	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—muscle cancer	7.43e-05	0.00229	CcSEcCtD
Vorinostat—Cough—Doxorubicin—muscle cancer	7.38e-05	0.00228	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—muscle cancer	7.2e-05	0.00222	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle—BUB1B—muscle cancer	7.18e-05	0.000861	CbGpPWpGaD
Vorinostat—HDAC8—Disease—ENO2—muscle cancer	7.18e-05	0.000861	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—MDM2—muscle cancer	7.11e-05	0.000852	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HMGA1—muscle cancer	7.07e-05	0.000848	CbGpPWpGaD
Vorinostat—Dry mouth—Doxorubicin—muscle cancer	7.04e-05	0.00217	CcSEcCtD
Vorinostat—NCOR1—Developmental Biology—FOXO1—muscle cancer	7.03e-05	0.000843	CbGpPWpGaD
Vorinostat—HDAC6—Disease—FOXO4—muscle cancer	7.01e-05	0.000841	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—muscle cancer	6.97e-05	0.000836	CbGpPWpGaD
Vorinostat—Decreased appetite—Methotrexate—muscle cancer	6.93e-05	0.00214	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—muscle cancer	6.88e-05	0.00212	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—muscle cancer	6.87e-05	0.00212	CcSEcCtD
Vorinostat—Infection—Doxorubicin—muscle cancer	6.86e-05	0.00212	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—PTCH1—muscle cancer	6.82e-05	0.000817	CbGpPWpGaD
Vorinostat—Shock—Doxorubicin—muscle cancer	6.79e-05	0.0021	CcSEcCtD
Vorinostat—HDAC1—Signaling by NGF—KIT—muscle cancer	6.76e-05	0.000811	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Doxorubicin—muscle cancer	6.76e-05	0.00209	CcSEcCtD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	6.74e-05	0.000808	CbGpPWpGaD
Vorinostat—HDAC9—Disease—ENO2—muscle cancer	6.72e-05	0.000805	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	6.7e-05	0.000804	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NOTCH—TP53—muscle cancer	6.61e-05	0.000792	CbGpPWpGaD
Vorinostat—Anorexia—Doxorubicin—muscle cancer	6.58e-05	0.00203	CcSEcCtD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	6.57e-05	0.000787	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MED12—muscle cancer	6.55e-05	0.000785	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HMGA1—muscle cancer	6.53e-05	0.000783	CbGpPWpGaD
Vorinostat—HDAC4—Disease—FOXO4—muscle cancer	6.34e-05	0.000761	CbGpPWpGaD
Vorinostat—Body temperature increased—Methotrexate—muscle cancer	6.3e-05	0.00195	CcSEcCtD
Vorinostat—HDAC6—Cellular responses to stress—TP53—muscle cancer	6.2e-05	0.000743	CbGpPWpGaD
Vorinostat—HDAC11—Disease—FOXO1—muscle cancer	6.18e-05	0.000741	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—IGF2—muscle cancer	6.11e-05	0.000732	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HMGA1—muscle cancer	6.11e-05	0.000732	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—MDM2—muscle cancer	6.08e-05	0.000729	CbGpPWpGaD
Vorinostat—HDAC3—Disease—ENO2—muscle cancer	6.03e-05	0.000723	CbGpPWpGaD
Vorinostat—Decreased appetite—Doxorubicin—muscle cancer	6e-05	0.00185	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—muscle cancer	5.96e-05	0.00184	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—muscle cancer	5.95e-05	0.00184	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—muscle cancer	5.9e-05	0.00182	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—FOXO4—muscle cancer	5.86e-05	0.000703	CbGpPWpGaD
Vorinostat—HDAC8—Disease—FOXO4—muscle cancer	5.85e-05	0.000702	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle, Mitotic—CDKN2A—muscle cancer	5.83e-05	0.000699	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CNR1—muscle cancer	5.75e-05	0.00069	CbGpPWpGaD
Vorinostat—Asthenia—Methotrexate—muscle cancer	5.72e-05	0.00177	CcSEcCtD
Vorinostat—HDAC2—Signaling by NGF—FOXO1—muscle cancer	5.72e-05	0.000686	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PTCH1—muscle cancer	5.71e-05	0.000685	CbGpPWpGaD
Vorinostat—HDAC1—TGF-beta Signaling Pathway—TP53—muscle cancer	5.67e-05	0.00068	CbGpPWpGaD
Vorinostat—Pruritus—Methotrexate—muscle cancer	5.64e-05	0.00174	CcSEcCtD
Vorinostat—NCOR1—Disease—ENO2—muscle cancer	5.55e-05	0.000665	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—MED12—muscle cancer	5.54e-05	0.000665	CbGpPWpGaD
Vorinostat—HDAC1—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	5.54e-05	0.000664	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HMGA1—muscle cancer	5.48e-05	0.000658	CbGpPWpGaD
Vorinostat—HDAC9—Disease—FOXO4—muscle cancer	5.48e-05	0.000657	CbGpPWpGaD
Vorinostat—Body temperature increased—Doxorubicin—muscle cancer	5.46e-05	0.00168	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—muscle cancer	5.45e-05	0.00168	CcSEcCtD
Vorinostat—HDAC3—Circadian rythm related genes—TP53—muscle cancer	5.41e-05	0.000648	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—TP53—muscle cancer	5.35e-05	0.000641	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MED12—muscle cancer	5.34e-05	0.00064	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—MDM2—muscle cancer	5.32e-05	0.000638	CbGpPWpGaD
Vorinostat—Dizziness—Methotrexate—muscle cancer	5.27e-05	0.00163	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—CDKN2A—muscle cancer	5.21e-05	0.000625	CbGpPWpGaD
Vorinostat—HDAC6—Disease—FOXO1—muscle cancer	5.18e-05	0.000621	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PTCH1—muscle cancer	5.17e-05	0.000619	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—MED12—muscle cancer	5.09e-05	0.000611	CbGpPWpGaD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—TP53—muscle cancer	5.09e-05	0.000611	CbGpPWpGaD
Vorinostat—Vomiting—Methotrexate—muscle cancer	5.07e-05	0.00156	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—MDM2—muscle cancer	5.06e-05	0.000606	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—ENO2—muscle cancer	5.05e-05	0.000606	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HMGA1—muscle cancer	5.04e-05	0.000604	CbGpPWpGaD
Vorinostat—Headache—Methotrexate—muscle cancer	4.99e-05	0.00154	CcSEcCtD
Vorinostat—NCOR1—Circadian rythm related genes—TP53—muscle cancer	4.97e-05	0.000596	CbGpPWpGaD
Vorinostat—Asthenia—Doxorubicin—muscle cancer	4.95e-05	0.00153	CcSEcCtD
Vorinostat—HDAC3—Disease—FOXO4—muscle cancer	4.92e-05	0.00059	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIDINS220—muscle cancer	4.91e-05	0.000589	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—FOXO4—muscle cancer	4.91e-05	0.000589	CbGpPWpGaD
Vorinostat—Pruritus—Doxorubicin—muscle cancer	4.88e-05	0.00151	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—CNR1—muscle cancer	4.82e-05	0.000578	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTCH1—muscle cancer	4.77e-05	0.000572	CbGpPWpGaD
Vorinostat—Nausea—Methotrexate—muscle cancer	4.74e-05	0.00146	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—muscle cancer	4.72e-05	0.00146	CcSEcCtD
Vorinostat—HDAC11—Disease—KIT—muscle cancer	4.71e-05	0.000565	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IGF2—muscle cancer	4.7e-05	0.000564	CbGpPWpGaD
Vorinostat—HDAC4—Disease—FOXO1—muscle cancer	4.69e-05	0.000562	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—ENO2—muscle cancer	4.64e-05	0.000557	CbGpPWpGaD
Vorinostat—Dizziness—Doxorubicin—muscle cancer	4.56e-05	0.00141	CcSEcCtD
Vorinostat—NCOR1—Disease—FOXO4—muscle cancer	4.52e-05	0.000542	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ENO2—muscle cancer	4.52e-05	0.000542	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—TP53—muscle cancer	4.49e-05	0.000539	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTCH1—muscle cancer	4.46e-05	0.000535	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—FOXO4—muscle cancer	4.44e-05	0.000533	CbGpPWpGaD
Vorinostat—Vomiting—Doxorubicin—muscle cancer	4.39e-05	0.00135	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—CNR1—muscle cancer	4.36e-05	0.000523	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—KIT—muscle cancer	4.36e-05	0.000522	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—FOXO1—muscle cancer	4.33e-05	0.000519	CbGpPWpGaD
Vorinostat—Headache—Doxorubicin—muscle cancer	4.32e-05	0.00133	CcSEcCtD
Vorinostat—HDAC8—Disease—FOXO1—muscle cancer	4.32e-05	0.000518	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NOTCH—TP53—muscle cancer	4.26e-05	0.000511	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HMGA1—muscle cancer	4.11e-05	0.000493	CbGpPWpGaD
Vorinostat—Nausea—Doxorubicin—muscle cancer	4.1e-05	0.00127	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—FOXO4—muscle cancer	4.1e-05	0.000492	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—TP53—muscle cancer	4.05e-05	0.000486	CbGpPWpGaD
Vorinostat—HDAC9—Disease—FOXO1—muscle cancer	4.04e-05	0.000485	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CNR1—muscle cancer	4.02e-05	0.000483	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTCH1—muscle cancer	4.01e-05	0.00048	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.95e-05	0.000474	CbGpPWpGaD
Vorinostat—HDAC6—Disease—KIT—muscle cancer	3.95e-05	0.000473	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IGF2—muscle cancer	3.94e-05	0.000473	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—IGF2—muscle cancer	3.94e-05	0.000472	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—FOXO4—muscle cancer	3.83e-05	0.00046	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CNR1—muscle cancer	3.76e-05	0.000451	CbGpPWpGaD
Vorinostat—HDAC11—Disease—MDM2—muscle cancer	3.71e-05	0.000445	CbGpPWpGaD
Vorinostat—HDAC1—Disease—FOXO4—muscle cancer	3.68e-05	0.000442	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTCH1—muscle cancer	3.68e-05	0.000441	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.67e-05	0.00044	CbGpPWpGaD
Vorinostat—HDAC3—Disease—FOXO1—muscle cancer	3.63e-05	0.000436	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.63e-05	0.000435	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—FOXO1—muscle cancer	3.63e-05	0.000435	CbGpPWpGaD
Vorinostat—HDAC11—Disease—PTGS2—muscle cancer	3.58e-05	0.000429	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KIT—muscle cancer	3.57e-05	0.000428	CbGpPWpGaD
Vorinostat—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	3.57e-05	0.000428	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IGF2—muscle cancer	3.57e-05	0.000427	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—TP53—muscle cancer	3.49e-05	0.000418	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—VEGFA—muscle cancer	3.49e-05	0.000418	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—FOXO4—muscle cancer	3.44e-05	0.000413	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MED12—muscle cancer	3.44e-05	0.000413	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—MDM2—muscle cancer	3.43e-05	0.000411	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CNR1—muscle cancer	3.38e-05	0.000405	CbGpPWpGaD
Vorinostat—NCOR1—Disease—FOXO1—muscle cancer	3.34e-05	0.0004	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KIT—muscle cancer	3.3e-05	0.000396	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KIT—muscle cancer	3.29e-05	0.000395	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IGF2—muscle cancer	3.29e-05	0.000394	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CDKN2A—muscle cancer	3.28e-05	0.000394	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—FOXO1—muscle cancer	3.28e-05	0.000393	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—VEGFA—muscle cancer	3.2e-05	0.000384	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MDM2—muscle cancer	3.18e-05	0.000382	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FOXO4—muscle cancer	3.17e-05	0.00038	CbGpPWpGaD
Vorinostat—HDAC6—Disease—MDM2—muscle cancer	3.11e-05	0.000373	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CNR1—muscle cancer	3.11e-05	0.000373	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KIT—muscle cancer	3.08e-05	0.000369	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IGF2—muscle cancer	3.08e-05	0.000369	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—FOXO1—muscle cancer	3.03e-05	0.000363	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTCH1—muscle cancer	3e-05	0.00036	CbGpPWpGaD
Vorinostat—HDAC6—Disease—PTGS2—muscle cancer	3e-05	0.000359	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ENO2—muscle cancer	2.91e-05	0.000349	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—TP53—muscle cancer	2.9e-05	0.000348	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—FOXO1—muscle cancer	2.83e-05	0.00034	CbGpPWpGaD
Vorinostat—HDAC4—Disease—MDM2—muscle cancer	2.81e-05	0.000337	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KIT—muscle cancer	2.77e-05	0.000332	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IGF2—muscle cancer	2.76e-05	0.000331	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KIT—muscle cancer	2.76e-05	0.000331	CbGpPWpGaD
Vorinostat—HDAC1—Disease—FOXO1—muscle cancer	2.72e-05	0.000326	CbGpPWpGaD
Vorinostat—HDAC4—Disease—PTGS2—muscle cancer	2.71e-05	0.000325	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HMGA1—muscle cancer	2.65e-05	0.000317	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—TP53—muscle cancer	2.61e-05	0.000313	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MDM2—muscle cancer	2.6e-05	0.000311	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MDM2—muscle cancer	2.59e-05	0.000311	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FOXO4—muscle cancer	2.58e-05	0.000309	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—VEGFA—muscle cancer	2.56e-05	0.000307	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—FOXO1—muscle cancer	2.54e-05	0.000305	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KIT—muscle cancer	2.54e-05	0.000305	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IGF2—muscle cancer	2.54e-05	0.000305	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CNR1—muscle cancer	2.53e-05	0.000304	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PTGS2—muscle cancer	2.5e-05	0.0003	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KIT—muscle cancer	2.5e-05	0.0003	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MDM2—muscle cancer	2.43e-05	0.000291	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FOXO4—muscle cancer	2.37e-05	0.000285	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PTGS2—muscle cancer	2.34e-05	0.000281	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FOXO1—muscle cancer	2.34e-05	0.00028	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KIT—muscle cancer	2.31e-05	0.000277	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MDM2—muscle cancer	2.18e-05	0.000261	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MDM2—muscle cancer	2.18e-05	0.000261	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KIT—muscle cancer	2.16e-05	0.000259	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PTGS2—muscle cancer	2.1e-05	0.000252	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KIT—muscle cancer	2.07e-05	0.000249	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF2—muscle cancer	2.07e-05	0.000248	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MDM2—muscle cancer	2e-05	0.00024	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—VEGFA—muscle cancer	1.97e-05	0.000237	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MDM2—muscle cancer	1.97e-05	0.000236	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KIT—muscle cancer	1.94e-05	0.000232	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—muscle cancer	1.94e-05	0.000232	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTCH1—muscle cancer	1.93e-05	0.000232	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTGS2—muscle cancer	1.93e-05	0.000232	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FOXO1—muscle cancer	1.91e-05	0.000229	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—muscle cancer	1.83e-05	0.000219	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MDM2—muscle cancer	1.82e-05	0.000218	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KIT—muscle cancer	1.78e-05	0.000214	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTGS2—muscle cancer	1.76e-05	0.000211	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FOXO1—muscle cancer	1.75e-05	0.00021	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MDM2—muscle cancer	1.7e-05	0.000204	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FOXO4—muscle cancer	1.66e-05	0.000199	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—muscle cancer	1.65e-05	0.000198	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—muscle cancer	1.65e-05	0.000198	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MDM2—muscle cancer	1.63e-05	0.000196	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CNR1—muscle cancer	1.63e-05	0.000196	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—muscle cancer	1.62e-05	0.000194	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—muscle cancer	1.57e-05	0.000189	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MDM2—muscle cancer	1.53e-05	0.000183	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—muscle cancer	1.5e-05	0.000179	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—muscle cancer	1.49e-05	0.000179	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KIT—muscle cancer	1.45e-05	0.000174	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MDM2—muscle cancer	1.4e-05	0.000168	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—muscle cancer	1.38e-05	0.000165	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KIT—muscle cancer	1.34e-05	0.00016	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF2—muscle cancer	1.33e-05	0.00016	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—muscle cancer	1.29e-05	0.000155	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—muscle cancer	1.25e-05	0.00015	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—muscle cancer	1.25e-05	0.00015	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FOXO1—muscle cancer	1.23e-05	0.000147	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—muscle cancer	1.16e-05	0.000139	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MDM2—muscle cancer	1.14e-05	0.000137	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—muscle cancer	1.13e-05	0.000135	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—muscle cancer	1.07e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MDM2—muscle cancer	1.05e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—muscle cancer	1.04e-05	0.000125	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—muscle cancer	1.01e-05	0.000122	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—muscle cancer	9.75e-06	0.000117	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIT—muscle cancer	9.36e-06	0.000112	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—muscle cancer	8.76e-06	0.000105	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—muscle cancer	8.68e-06	0.000104	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—muscle cancer	8.05e-06	9.65e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MDM2—muscle cancer	7.37e-06	8.84e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—muscle cancer	6.56e-06	7.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—muscle cancer	5.6e-06	6.71e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—muscle cancer	4.23e-06	5.07e-05	CbGpPWpGaD
